We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

BD DIAGNOSTIC SYSTEMS

BD Diagnostics manufactures and markets medical supplies and devices and diagnostic systems that include cellular ana... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 Jun 2020 - 09 Jun 2020
Virtual Venue
08 Jun 2020 - 11 Jun 2020
Virtual Venue

Different Methods Compared for Species Identification of Enterococcus

By LabMedica International staff writers
Posted on 18 May 2020
Print article
Image: The BD Phoenix M50 Automated Microbiology System provides clinicians with accurate and timely identification and susceptibility results to help guide their therapy and patient management decisions (Photo courtesy of Becton‐Dickinson).
Image: The BD Phoenix M50 Automated Microbiology System provides clinicians with accurate and timely identification and susceptibility results to help guide their therapy and patient management decisions (Photo courtesy of Becton‐Dickinson).
Biochemical test‐based methodologies are still used in some laboratories for the identification of bacterial isolates, mainly because of the need for the performance of drug susceptibility tests. However, these systems are unable to distinguish some species, especially among Gram‐positive bacteria.

Matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS) is an efficient method used in clinical microbiology laboratories for the identification of clinically relevant microorganisms. Microorganisms can be identified using a reference database in a turnaround time of minutes, which is essential when rapid results are needed.

Medical Scientists at the Universidad Autónoma de Nuevo León (Monterrey, Mexico) evaluated the performance of two commercial MALDI‐TOF MS systems and three biochemical‐based systems and compared them to whole genome sequencing (WGS) as the gold standard for identifying isolates of vancomycin‐resistant enterococci (VRE). A total of 87 VRE clinical isolates recovered from urine (33%), soft tissue (24%), blood (16%), and other specimens (27%) were identified by the systems.

For both MALDI‐TOF instruments, the direct method was used for identification. The mass spectrometers were the Microflex system with Biotyper software 3.1 (Biotyper; Bruker Daltonics, Bremen, Germany) and the Vitek MS system (bioMérieux, Marcy l'Etoile, France). The biochemical‐based systems included the bioMérieux Vitek 2, Phoenix (Becton‐Dickinson, Franklin Lakes, NJ, USA), and MicroScan WalkAway (Siemens Healthcare Diagnostics, Munich, Germany) systems. Paired‐end sequencing runs were performed on an Illumina MiSeq instrument (Illumina, San Diego, CA, USA).

The scientists reported that among the 87 VRE, 71 and 16 were identified as Enterococcus faecium and Enterococcus faecalis by WGS. All 71 E. faecium were correctly identified by both mass spectrometers, as well as the Vitek 2 and Phoenix instruments. However, only 51 E. faecium isolates were correctly identified by the MicroScan system. The most frequent misidentification was Enterococcus casseliflavus (n = 20). For vancomycin‐resistant E. faecium, the Microflex Biotyper system had the highest sensitivity (85.54%), and all instruments (except for the MicroScan) had a 100% specificity and positive predictive value (PPV). Up to 87% of E. faecalis isolates were misidentified by VITEK MS and VITEK2, 81% by MicroScan and Phoenix, and 75% by Bruker biotyper. The NPV was lower than 38% for all devices. The instrument with the highest accuracy was the Bruker Biotyper system (86.21%).

The authors concluded that as the coverage of type strain‐genome sequence database continues to grow and the cost of DNA sequencing continues to decrease, genome‐based identification can be a useful tool for diagnostic laboratories, with its superior accuracy even over MALDI‐TOF and database‐driven operations. The study was published on May 1, 2020 in the Journal of Clinical Laboratory Analysis.




Print article

Channels

Copyright © 2000-2020 Globetech Media. All rights reserved.